More articles from Cystic fibrosis

Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β₁ are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa
Jan C. Thomassen, Tobias Trojan, Maxine Walz, Christina Vohlen, Gregor Fink, Ernst Rietschel, Miguel A. Alejandre Alcazar, Silke van Koningsbruggen-Rietschel

ERJ Open Research Jul 2021, 7 (3) 00636-2020; DOI: 10.1183/23120541.00636-2020
Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
Charlotte Marsac, Laura Berdah, Guillaume Thouvenin, Isabelle Sermet-Gaudelus, Harriet Corvol

ERJ Open Research Apr 2021, 7 (2) 00076-2021; DOI: 10.1183/23120541.00076-2021
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
Lindsay J. Caverly, Madsen Zimbric, Michelle Azar, Kristopher Opron, John J. LiPuma

ERJ Open Research Apr 2021, 7 (2) 00578-2020; DOI: 10.1183/23120541.00578-2020
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Anne H. Neerincx, Katrine Whiteson, Joann L. Phan, Paul Brinkman, Mahmoud I. Abdel-Aziz, Els J.M. Weersink, Josje Altenburg, Christof J. Majoor, Anke H. Maitland-van der Zee, Lieuwe D.J. Bos

ERJ Open Research Apr 2021, 7 (2) 00731-2020; DOI: 10.1183/23120541.00731-2020
Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
Christophe Marguet, Véronique Houdouin, Isabelle Pin, Philippe Reix, Frédéric Huet, Marie Mittaine, Sophie Ramel, Nathalie Wizla-Derambure, Michel Abely, Marie-Laure Dalphin, Michael Fayon, Tiphaine Bihouée, Muriel Le Bourgeois, Eric Deneuville, Harriet Corvol, Muriel Laurans, Laure Couderc, Evelyne Leroux, Ludovic Lémée

ERJ Open Research Jan 2021, 7 (1) 00513-2020; DOI: 10.1183/23120541.00513-2020
First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold

ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos

ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
Laura K. Fawcett, Claire E. Wakefield, Sheila Sivam, Peter G. Middleton, Peter Wark, John Widger, Adam Jaffe, Shafagh A. Waters

ERJ Open Research Jan 2021, 7 (1) 00448-2020; DOI: 10.1183/23120541.00448-2020
Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis
Tobias Engel, Paul E. Verweij, Joost van den Heuvel, Dechen Wangmo, Jianhua Zhang, Alfons J.M. Debets, Eveline Snelders

ERJ Open Research Oct 2020, 6 (4) 00020-2020; DOI: 10.1183/23120541.00020-2020
Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis
Peter Nickolaus, Birgit Jung, Juan Sabater, Samuel Constant, Abhya Gupta

ERJ Open Research Oct 2020, 6 (4) 00429-2020; DOI: 10.1183/23120541.00429-2020

Main menu

User menu

Search

More articles from Cystic fibrosis

Pages

Contact us